{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T17:41:17Z","timestamp":1779298877854,"version":"3.51.4"},"reference-count":49,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes &amp; Metabolic Syndrome: Clinical Research &amp; Reviews"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.dsx.2018.07.007","type":"journal-article","created":{"date-parts":[[2018,7,17]],"date-time":"2018-07-17T12:50:32Z","timestamp":1531831832000},"page":"3035-3041","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["An investigation of the association between the level of prolactin in serum and type II diabetes"],"prefix":"10.1016","volume":"13","author":[{"given":"Najmeh","family":"Manshaei","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feloria","family":"Shakibaei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Fazilati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hossein","family":"Salavati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masoud","family":"Negahdary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abbasali","family":"Palizban","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.dsx.2018.07.007_bib1","first-page":"368","article-title":"The history of diabetes mellitus","volume":"13","author":"Lakhtakia","year":"2013","journal-title":"Sultan Qaboos Univ. Med. J."},{"key":"10.1016\/j.dsx.2018.07.007_bib2","series-title":"Diabetes its medical and cultural history: outlines \u2014 texts \u2014 bibliography","author":"Engelhardt","year":"2012"},{"key":"10.1016\/j.dsx.2018.07.007_bib3","doi-asserted-by":"crossref","DOI":"10.1096\/fj.02-0974bkt","article-title":"New weapons to combat an ancient disease: treating diabetes","volume":"16","author":"Patlak","year":"2002","journal-title":"Faseb J"},{"key":"10.1016\/j.dsx.2018.07.007_bib4","series-title":"Robbins and Cotran pathologic basis of disease","author":"Kumar","year":"2005"},{"key":"10.1016\/j.dsx.2018.07.007_bib5","first-page":"1","article-title":"Classification, pathophysiology, diagnosis and management of diabetes mellitus","volume":"6","author":"Baynest","year":"2015","journal-title":"J.\u00a0Diabetes Metabol."},{"key":"10.1016\/j.dsx.2018.07.007_bib6","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S","article-title":"Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation","volume":"15","author":"Alberti","year":"1998","journal-title":"Diabet. Med. : J. Br. Diabet. Assoc."},{"key":"10.1016\/j.dsx.2018.07.007_bib7","article-title":"Diagnosis and classification of diabetes mellitus","volume":"33","author":"Association AD","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.dsx.2018.07.007_bib8","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1152\/physiol.00010.2007","article-title":"Brain glucose sensing, counterregulation, and energy homeostasis","volume":"22","author":"Marty","year":"2007","journal-title":"Physiology"},{"key":"10.1016\/j.dsx.2018.07.007_bib9","series-title":"Harrison's principles of internal medicine","author":"Kasper","year":"2015"},{"key":"10.1016\/j.dsx.2018.07.007_bib10","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1111\/jmwh.12319","article-title":"Physiologic breastfeeding: a contemporary approach to breastfeeding initiation","volume":"60","author":"Schafer","year":"2015","journal-title":"J\u00a0Midwifery Wom Health"},{"key":"10.1016\/j.dsx.2018.07.007_bib11","series-title":"Essential biochemistry","author":"Pratt","year":"2004"},{"key":"10.1016\/j.dsx.2018.07.007_bib12","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.2337\/dc12-1893","article-title":"Circulating prolactin associates with diabetes and impaired glucose regulation: a population-based study","volume":"36","author":"Wang","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.dsx.2018.07.007_bib13","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1677\/JOE-07-0043","article-title":"Regulation of glucokinase in pancreatic islets by prolactin: a mechanism for increasing glucose-stimulated insulin secretion during pregnancy","volume":"193","author":"Weinhaus","year":"2007","journal-title":"J\u00a0Endocrinol"},{"key":"10.1016\/j.dsx.2018.07.007_bib14","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1210\/endo.133.3.8365359","article-title":"Effects of sex and pregnancy hormones on growth hormone and prolactin receptor gene expression in insulin-producing cells","volume":"133","author":"M\u00f8ldrup","year":"1993","journal-title":"Endocrinology"},{"key":"10.1016\/j.dsx.2018.07.007_bib15","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1055\/s-2007-979040","article-title":"Adaptation of islets of langerhans to pregnancy: b-cell growth, enhanced insulin secretion and the role","volume":"29","author":"Sorenson","year":"1997","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.dsx.2018.07.007_bib16","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.mce.2006.09.011","article-title":"Beneficial effects of prolactin and laminin on human pancreatic islet-cell cultures","volume":"263","author":"Labriola","year":"2007","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.dsx.2018.07.007_bib17","doi-asserted-by":"crossref","first-page":"30707","DOI":"10.1074\/jbc.M702607200","article-title":"Lactogens promote beta cell survival through JAK2\/STAT5 activation and Bcl-XL upregulation","volume":"282","author":"Fujinaka","year":"2007","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.dsx.2018.07.007_bib18","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1210\/jc.2002-021137","article-title":"Identification of functional prolactin (PRL) receptor gene expression: PRL inhibits lipoprotein lipase activity in human white adipose tissue","volume":"88","author":"Ling","year":"2003","journal-title":"J.\u00a0Clin. Endocrinol. Metabol."},{"key":"10.1016\/j.dsx.2018.07.007_bib19","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.2337\/diabetes.54.7.1968","article-title":"The regulation of fatty acid synthase by STAT5A","volume":"54","author":"Hogan","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.dsx.2018.07.007_bib20","doi-asserted-by":"crossref","first-page":"268","DOI":"10.2337\/diabetes.52.2.268","article-title":"Sexual differentiation, pregnancy, calorie restriction, and aging affect the adipocyte-specific secretory protein adiponectin","volume":"52","author":"Combs","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/j.dsx.2018.07.007_bib21","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1210\/en.2005-0989","article-title":"LS14: a novel human adipocyte cell line that produces prolactin","volume":"147","author":"Hugo","year":"2006","journal-title":"Endocrinology"},{"key":"10.1016\/j.dsx.2018.07.007_bib22","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/j.1463-1326.2006.00671.x","article-title":"Adipocyte prolactin: regulation of release and putative functions","volume":"9","author":"Brandebourg","year":"2007","journal-title":"Diabetes Obes Metabol"},{"key":"10.1016\/j.dsx.2018.07.007_bib23","doi-asserted-by":"crossref","first-page":"4638","DOI":"10.1210\/en.2006-0487","article-title":"The prolactin-deficient mouse has an unaltered metabolic phenotype","volume":"147","author":"LaPensee","year":"2006","journal-title":"Endocrinology"},{"key":"10.1016\/j.dsx.2018.07.007_bib24","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1002\/dmrr.1215","article-title":"Serum prolactin concentrations determine whether they improve or impair \u03b2-cell function and insulin sensitivity in diabetic rats","volume":"27","author":"Park","year":"2011","journal-title":"Diabetes Metabol. Res. Rev."},{"key":"10.1016\/j.dsx.2018.07.007_bib25","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1159\/000336501","article-title":"Central prolactin modulates insulin sensitivity and insulin secretion in diabetic rats","volume":"95","author":"Park","year":"2012","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.dsx.2018.07.007_bib26","doi-asserted-by":"crossref","first-page":"8074","DOI":"10.1523\/JNEUROSCI.0129-12.2012","article-title":"Prolactin regulates tuberoinfundibular dopamine neuron discharge pattern: novel feedback control mechanisms in the lactotrophic axis","volume":"32","author":"Lyons","year":"2012","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.dsx.2018.07.007_bib27","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s11102-010-0277-9","article-title":"Insulin sensitivity and lipid profile in prolactinoma patients before and after normalization of prolactin by dopamine agonist therapy","volume":"14","author":"Berinder","year":"2011","journal-title":"Pituitary"},{"key":"10.1016\/j.dsx.2018.07.007_bib28","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1530\/eje.0.1470077","article-title":"Dopaminergic tone and obesity: an insight from prolactinomas treated with bromocriptine","volume":"147","author":"Doknic","year":"2002","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.dsx.2018.07.007_bib29","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1515\/JPEM.2005.18.9.921","article-title":"Reversible weight gain and prolactin levels-long-term follow-up in childhood","volume":"18","author":"Galluzzi","year":"2005","journal-title":"J\u00a0Pediatr Endocrinol Metabol"},{"key":"10.1016\/j.dsx.2018.07.007_bib30","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.tem.2006.02.005","article-title":"Focus on prolactin as a metabolic hormone","volume":"17","author":"Ben-Jonathan","year":"2006","journal-title":"Trends Endocrinol Metabol"},{"key":"10.1016\/j.dsx.2018.07.007_bib31","doi-asserted-by":"crossref","first-page":"4162","DOI":"10.1210\/en.2004-0201","article-title":"Distinctive roles for prolactin and growth hormone in the activation of signal transducer and activator of transcription 5 in pancreatic islets of langerhans","volume":"145","author":"Brelje","year":"2004","journal-title":"Endocrinology"},{"key":"10.1016\/j.dsx.2018.07.007_bib32","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1210\/endo.143.4.8722","article-title":"Targeted deletion of the PRL receptor: effects on islet development, insulin production, and glucose tolerance","volume":"143","author":"Freemark","year":"2002","journal-title":"Endocrinology"},{"key":"10.1016\/j.dsx.2018.07.007_bib33","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/j.1365-2265.2006.02469.x","article-title":"The influences of hyperprolactinemia and obesity on cardiovascular risk markers: effects of cabergoline therapy","volume":"64","author":"Serri","year":"2006","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.dsx.2018.07.007_bib34","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1038\/oby.2008.297","article-title":"Prolactin and insulin ultradian secretion and adipose tissue lipoprotein lipase expression in severely obese women after bariatric surgery","volume":"16","author":"Mingrone","year":"2008","journal-title":"Obesity"},{"key":"10.1016\/j.dsx.2018.07.007_bib35","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1007\/s11695-009-9856-0","article-title":"Basal serum prolactin levels in obesity\u2014unrelated to parameters of the metabolic syndrome and unchanged after massive weight loss","volume":"19","author":"Ernst","year":"2009","journal-title":"Obes Surg"},{"key":"10.1016\/j.dsx.2018.07.007_bib36","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0006-3223(94)91147-9","article-title":"Circadian rhythm of tryptophan, serotonin, melatonin, and pituitary hormones in schizophrenia","volume":"35","author":"Rao","year":"1994","journal-title":"Biol Psychiatr"},{"key":"10.1016\/j.dsx.2018.07.007_bib37","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/j.1464-5491.2007.02092.x","article-title":"Impaired glucose tolerance in first-episode drug-na\u00efve patients with schizophrenia","volume":"24","author":"Spelman","year":"2007","journal-title":"Diabet Med"},{"key":"10.1016\/j.dsx.2018.07.007_bib38","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.1002\/jcp.24023","article-title":"Potential role of prolactin in antipsychotic-mediated association of schizophrenia and type 2 diabetes","volume":"227","author":"Oberweis","year":"2012","journal-title":"J\u00a0Cell Physiol"},{"key":"10.1016\/j.dsx.2018.07.007_bib39","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/S0024-3205(02)01775-7","article-title":"Prolactin and schizophrenia: clinical consequences of hyperprolactinaemia","volume":"71","author":"Meaney","year":"2002","journal-title":"Life Sci"},{"key":"10.1016\/j.dsx.2018.07.007_bib40","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1176\/appi.ajp.160.2.284","article-title":"Impaired fasting glucose tolerance in first-episode, drug-naive patients with schizophrenia","volume":"160","author":"Ryan","year":"2003","journal-title":"Am J Psychiatr"},{"key":"10.1016\/j.dsx.2018.07.007_bib41","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1210\/jc.2005-1654","article-title":"The metabolic syndrome is associated with reduced central serotonergic responsivity in healthy community volunteers","volume":"91","author":"Muldoon","year":"2006","journal-title":"J.\u00a0Clin. Endocrinol. Metabol."},{"key":"10.1016\/j.dsx.2018.07.007_bib42","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1210\/jc.2003-031295","article-title":"Low central nervous system serotonergic responsivity is associated with the metabolic syndrome and physical inactivity","volume":"89","author":"Muldoon","year":"2004","journal-title":"J.\u00a0Clin. Endocrinol. Metabol."},{"key":"10.1016\/j.dsx.2018.07.007_bib43","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s11102-010-0277-9","article-title":"Insulin sensitivity and lipid profile in prolactinoma patients before and after normalization of prolactin by dopamine agonist therapy","volume":"14","author":"Berinder","year":"2011","journal-title":"Pituitary"},{"key":"10.1016\/j.dsx.2018.07.007_bib44","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s13098-015-0094-4","article-title":"Metabolic abnormalities in patients with prolactinoma: response to treatment with cabergoline","volume":"7","author":"Pala","year":"2015","journal-title":"Diabetol Metab Syndrome"},{"key":"10.1016\/j.dsx.2018.07.007_bib45","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1677\/JOE-07-0043","article-title":"Regulation of glucokinase in pancreatic islets by prolactin: a mechanism for increasing glucose-stimulated insulin secretion during pregnancy","volume":"193","author":"Weinhaus","year":"2007","journal-title":"J\u00a0Endocrinol"},{"key":"10.1016\/j.dsx.2018.07.007_bib46","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.transproceed.2008.01.009","article-title":"beta-Cell specific cytoprotection by prolactin on human islets","volume":"40","author":"Yamamoto","year":"2008","journal-title":"Transplant Proc"},{"key":"10.1016\/j.dsx.2018.07.007_bib47","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1097\/TP.0b013e3181d98af1","article-title":"Prolactin supplementation to culture medium improves beta-cell survival","volume":"89","author":"Yamamoto","year":"2010","journal-title":"Transplantation"},{"key":"10.1016\/j.dsx.2018.07.007_bib48","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1007\/s00125-011-2102-z","article-title":"Recombinant human prolactin promotes human beta cell survival via inhibition of extrinsic and intrinsic apoptosis pathways","volume":"54","author":"Terra","year":"2011","journal-title":"Diabetologia"},{"key":"10.1016\/j.dsx.2018.07.007_bib49","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1472-6823-13-12","article-title":"Serum prolactin concentrations as risk factor of metabolic syndrome or type 2 diabetes?","volume":"13","author":"Balbach","year":"2013","journal-title":"BMC Endocr Disord"}],"container-title":["Diabetes &amp; Metabolic Syndrome: Clinical Research &amp; Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402118302649?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402118302649?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T09:09:37Z","timestamp":1761728977000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1871402118302649"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":49,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["S1871402118302649"],"URL":"https:\/\/doi.org\/10.1016\/j.dsx.2018.07.007","relation":{},"ISSN":["1871-4021"],"issn-type":[{"value":"1871-4021","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An investigation of the association between the level of prolactin in serum and type II diabetes","name":"articletitle","label":"Article Title"},{"value":"Diabetes & Metabolic Syndrome: Clinical Research & Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dsx.2018.07.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Ltd on behalf of Diabetes India.","name":"copyright","label":"Copyright"}]}}